共 215 条
[1]
Ross JS(2009)The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine Oncologist 14 320-68
[2]
Slodkowska EA(2007)Trastuzumab—mechanism of action and use in clinical practice N Engl J Med 357 39-51
[3]
Symmans WF(2008)Immunoglobulin G fragment C receptor polymorphisms and clinical efficacy of trastuzumab-based therapy in patients with HER-2/ J Clin Oncol 26 1789-96
[4]
Pusztai L(2010)–positive metastatic breast cancer Cancer Cell 18 160-70
[5]
Ravdin PM(2006)The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity Breast Cancer Res 8 215-27
[6]
Hortobagyi GN(2004)HER2 therapy: Molecular mechanisms of trastuzumab resistance Cancer Cell 6 117-9
[7]
Hudis CA(1997)PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients Int J Cancer 73 875-24
[8]
Musolino A(2004)Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cells Clin Cancer Res 10 1618-91
[9]
Naldi N(2002)Monitoring of serum Her-2/ Int J Cancer 99 783-93
[10]
Bortesi B(2012) predicts response and progression-free survival to trastuzumab-based treatment in patients with metastatic breast cancer Breast Cancer Res Treat 134 583-7